FDA stepping up oversight of drug pumps

Apr 23, 2010 By MIKE STOBBE , AP Medical Writer

(AP) -- Federal health regulators on Friday announced steps to improve the design and safety of drug pumps that have been linked to more than 700 deaths in the past five years.

"It's clear from the history of problems we're seeing that there is a need for more careful infusion pump design and testing," said Dr. Jeffrey Shuren of the U.S. . He announced the initiative Friday at a health journalists' conference in Chicago.

Infusion pumps are used to deliver fluids - liquid nutrients and medicines like insulin, , or - into a patient's body. They are used in hospitals as well as by patients at home.

Over the past five years, the FDA has received reports linking 710 deaths to infusion pump problems, and that likely is an underestimate, said Shuren, the FDA's director of the Center for Devices and Radiological Health,

In the past, many problems were attributed to human error, a doctor or nurse thinking they mistyped infusion directions. But FDA officials believe that software and design issues are actually at the root of many of them.

The FDA is working on new guidelines that call on manufacturers to provide more detailed design and engineering information to FDA for new pumps. The FDA also wants manufacturers to try out the devices in settings where they are commonly used, and when necessary, it wants to be able to inspect the manufacturing plant before approving the device.

Explore further: New treatment approved for rare form of hemophilia

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

FDA to study negative effects of Lasik eye surgery

Oct 16, 2009

(AP) -- The Food and Drug Administration announced plans Thursday to study the scope of problems connected with laser eye-correcting surgery, which include blurred vision and dry eyes.

FDA OKs urinary infection injectable drug

Oct 18, 2007

The U.S. Food and Drug Administration announced approval Thursday of doripenem (Doribax) injections for the treatment of complex urinary track infections.

FDA OKs urinary infection injectable drug

Oct 18, 2007

The U.S. Food and Drug Administration announced approval Thursday of doripenem (Doribax) injections for the treatment of complex urinary tract infections.

FDA launches plan to curb accidental overdoses

Nov 04, 2009

(AP) -- The Food and Drug Administration is launching a program to try and prevent millions of accidental drug overdoses that occur each year due to medication errors, misuse and other problems.

FDA Web site explains agency operations to public

Jan 12, 2010

(AP) -- The Food and Drug Administration is launching a new Web site explaining its operations to consumers as part of a broader effort to rebrand itself as a more accessible agency.

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

12 hours ago

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments : 0